GSE128295
UM171 expands distinct types of myeloid and lymphoid progenitors from human pluripotent stem cells.
Overall, our studies revealed that UM171 differentially enriches specific populations of hematopoietic progenitors, in HSC expansion and lymphoid culture conditions, and that it is a potent small molecule agonist for expansion of granulocytic progenitors and lymphoid progenitors from hPSCs. Overall design: hPSC derived hematopoietic progenitors generated from H1 hESCs on day 9 of differerntiation (Uenishi et all, Stem cell Reports, 2014) expanded for 16 hrs or 5 days with UM171 were subject to gene expression profiling . DMSO treated hPSC derived hematopoietic progenitors were used as the vehicle control.